Clinical Trials Browser

Suspended × Interventional × Vemurafenib × Clear all

NCT01841463 2014-09-04

Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation

Phase 1 Suspended

Melanoma